Karyopharm Therapeutics Inc. · NASDAQ:KPTI

Abate Kristin sold 19 Karyopharm Therapeutics Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 2, 2026

On Sep 1, 2026, Abate Kristin (Chief Accounting Officer) sold 19 Karyopharm Therapeutics Inc. shares at US$2.02 for US$38, leaving 23,782 shares. Filed Sep 2, 2026 (Form 4).

Sold
19 shares
Price
US$2.02
Value
US$38
Holding after
23,782 shares
Trading plan
No
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockSale19US$2.0223,782Direct

Source

View original at SEC

Related